| Diane M Madsen, CRMA | |
|
401 E Spruce St, Garden City, KS 67846-5679 | |
| (620) 272-2222 | |
| Not Available |
| Full Name | Diane M Madsen |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 401 E Spruce St, Garden City, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568788677 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | TMP140632 (Kansas) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 76659 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Regional Medical Center - Plymouth | Plymouth, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ams Northern Indiana Llc | 8022444306 | 12 |
| Great Lakes Anesthesia Pc | 0648183442 | 11 |
News Archive
Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies.
These changes, known as epigenetic modifications, control the activity of our genes without changing the actual DNA sequence. One of the main epigenetic modifications is DNA methylation, which plays a key role in embryonic development and the formation of different cell types, regulating when and where genes are switched on.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
The Washington Post reports that as officials work toward the final enrollment season push, the administration is turning to some private entrepreneurs to help sign up people. Also, the Los Angeles Times examines how many young people are signing up.
› Verified 3 days ago
| Entity Name | Great Lakes Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720039977 PECOS PAC ID: 0648183442 Enrollment ID: O20031107000452 |
News Archive
Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies.
These changes, known as epigenetic modifications, control the activity of our genes without changing the actual DNA sequence. One of the main epigenetic modifications is DNA methylation, which plays a key role in embryonic development and the formation of different cell types, regulating when and where genes are switched on.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
The Washington Post reports that as officials work toward the final enrollment season push, the administration is turning to some private entrepreneurs to help sign up people. Also, the Los Angeles Times examines how many young people are signing up.
› Verified 3 days ago
| Entity Name | Ams Northern Indiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427619840 PECOS PAC ID: 8022444306 Enrollment ID: O20200205000244 |
News Archive
Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies.
These changes, known as epigenetic modifications, control the activity of our genes without changing the actual DNA sequence. One of the main epigenetic modifications is DNA methylation, which plays a key role in embryonic development and the formation of different cell types, regulating when and where genes are switched on.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
The Washington Post reports that as officials work toward the final enrollment season push, the administration is turning to some private entrepreneurs to help sign up people. Also, the Los Angeles Times examines how many young people are signing up.
› Verified 3 days ago
| Entity Name | Mason City Ambulatory Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689251720 PECOS PAC ID: 8123037140 Enrollment ID: O20210427000719 |
News Archive
Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies.
These changes, known as epigenetic modifications, control the activity of our genes without changing the actual DNA sequence. One of the main epigenetic modifications is DNA methylation, which plays a key role in embryonic development and the formation of different cell types, regulating when and where genes are switched on.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
The Washington Post reports that as officials work toward the final enrollment season push, the administration is turning to some private entrepreneurs to help sign up people. Also, the Los Angeles Times examines how many young people are signing up.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diane M Madsen, CRMA 2830 E Prestwick Rd, Winona Lake, IN 46590-8910 Ph: (620) 805-9113 | Diane M Madsen, CRMA 401 E Spruce St, Garden City, KS 67846-5679 Ph: (620) 272-2222 |
News Archive
Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies.
These changes, known as epigenetic modifications, control the activity of our genes without changing the actual DNA sequence. One of the main epigenetic modifications is DNA methylation, which plays a key role in embryonic development and the formation of different cell types, regulating when and where genes are switched on.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
The Washington Post reports that as officials work toward the final enrollment season push, the administration is turning to some private entrepreneurs to help sign up people. Also, the Los Angeles Times examines how many young people are signing up.
› Verified 3 days ago
Thomas Scott Troy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 411 N Campus, Garden City, KS 67846 Phone: 620-276-7699 | |
Christopher Friedly, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2222 | |
Chris P Omenski, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2222 Fax: 620-272-2216 | |
John Christian Newcomer, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2222 | |
Lynn Gage Dunford, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 411 N Campus, Garden City, KS 67846 Phone: 620-276-7699 | |
Kamau P Gitau, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3501 N Campus Dr, B204, Garden City, KS 67846 Phone: 208-604-2938 | |
Mr. Brian L Tackitt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2610 |